YOKNEAM, ISRAEL--(Marketwire - October 18, 2007) - Syneron Medical Ltd. (NASDAQ: ELOS) today announced that for the quarter ended September 30, 2007, preliminary results indicate revenues of approximately $33 million and net profit in the range of $7-8 million.
